Recombinant Human BRD4 Protein，His

BRD4 (Bromodomain-containing protein 4) is a crucial member of the BET (bromodomain and extraterminal domain) protein family, which plays a significant role in regulating gene expression by interacting with acetylated lysines on histones. Initially identified for its role in transcriptional activation and involvement in cell cycle regulation, BRD4 has garnered attention due to its implications in various cancers and other diseases, notably through its association with the expression of proto-oncogenes. The study of recombinant BRD4 proteins allows researchers to investigate the specific mechanisms of BRD4 function, its interactions with chromatin, and its potential as a therapeutic target. By producing BRD4 in a controlled laboratory setting, scientists can elucidate its structural and functional properties, screen for small molecule inhibitors, and explore its role as a co-activator in oncogenic pathways. Additionally, understanding BRD4's dynamic roles in cellular processes such as differentiation, inflammation, and viral replication is essential for developing targeted therapies. Given the promising results from preclinical studies with BET inhibitors in various cancer models, the research on BRD4-derived recombinant proteins is pivotal for advancing our understanding of its biology and enhancing drug discovery efforts tailored to combat diseases linked to aberrant BRD4 activity.